KZA 0.00% 8.0¢ kazia therapeutics limited

News: KZA Kazia Says Phase II Study Of Paxalisib In Brain Metastases Advances To Expansion Stage In...

  1. 186,785 Posts.
    lightbulb Created with Sketch. 2746

    June 7 (Reuters) - Kazia Therapeutics Ltd (KZA) :

    • PHASE II STUDY OF PAXALISIB IN BRAIN METASTASES ADVANCES TO EXPANSION STAGE IN BREAST CANCER BRAIN METASTASES COHORT
 
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.